Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Ocular Sarcoidosis Open Label Trial of ACTHAR Gel

NCT02725177 is registered in ClinicalTrials.gov with The Cleveland Clinic as lead sponsor.

NCT NCT02725177
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02725177 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Ocular Sarcoidosis Open Label Trial of ACTHAR Gel
Lead sponsor
The Cleveland Clinic
Phase
Not applicable
Overall status
Completed
Start date
July 31, 2016
Completion date
March 31, 2022
Enrollment
9 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

anterior uveitis, ocular sarcoidosis, panuveitis